A. Burn

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Nguyen H. Tran, Vidyashankara G. Iyer, Andreas C. Themistocleous, 2020, Lancet.

Polymerase chain reaction amplification of two polymorphic simple repeat sequences within the von Willebrand factor gene: application to family studies in von Willebrand disease

J. Armstrong, A. Cumming, R. Wensley, 1992, Human Genetics.

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Nguyen H. Tran, Vidyashankara G. Iyer, Andreas C. Themistocleous, 2021, The Lancet.

Plasma exchange and human factor VIII concentrate in managing haemophilia A with factor VIII inhibitors.

R. Stevens, R. Wensley, A. Burn, 1980, British medical journal.

Platelet responses to ristocetin in von Willebrand's disease.

A. Burn, J. H. Sanderson, S. Cooke, 2009, Scandinavian journal of haematology.

Increased Platelet Adhesiveness as a Familial Characteristic

C. Geary, A. Burn, M. Israëls, 1973, British journal of haematology.

Clinical and laboratory evaluation of National Health Service factor VIII concentrate (8Y) for the treatment of von Willebrand's disease

A. Cumming, R. Wensley, S. Fildes, 1990, British journal of haematology.

The effect of cryoprecipitate concentrate in patients with classical haemophilia.

K. E. Barrett, A. Burn, M. Israëls, 1967, Lancet.